(AKYA) Akoya Biosciences - Performance -34.9% in 12m
AKYA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-81.18%
#172 in Peer-Group
Rel. Strength
14.33%
#6575 in Stock-Universe
Total Return 12m
-34.93%
#150 in Peer-Group
Total Return 5y
-94.78%
#172 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 3.24 USD |
| 52 Week Low | 0.95 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 85.00 |
| Buy/Sell Signal +-5 | -0.23 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: AKYA (-34.9%) vs XLV (-4.6%)
5y Drawdown (Underwater) Chart
Top Performer in Health Care Equipment
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| STE NYSE STERIS |
-1.65% | 9.03% | 61.9% | 38.8 | 24 | 1.95 | 64.0% | 69.1% |
| ITGR NYSE Integer Holdings |
0.69% | 4.01% | 69.1% | 55.3 | 21.3 | 0.93 | 39.6% | -28.7% |
| RMD NYSE ResMed |
2.81% | 33.1% | 38.4% | 28.2 | 24.1 | 1.49 | 88.9% | 16.9% |
| SHL XETRA Siemens Healthineers |
1.78% | -10.8% | 21.2% | 25.2 | 18.4 | 1.12 | 12.9% | 7.65% |
| GMED NYSE Globus Medical |
-0.82% | -14% | 29.8% | 44.9 | 18.9 | 1.72 | -16.6% | 7.79% |
| DEMANT CO Demant |
4.71% | -10.4% | 41.5% | 20.1 | 19.8 | 0.95 | -3.70% | 7% |
| SOON SW Sonova H |
-5.78% | -13.1% | 25.4% | 26.6 | 19.5 | 1.76 | 35.7% | 36.3% |
| DRW3 XETRA Drägerwerk & Co. KGaA |
-4.35% | 39.3% | -7.21% | 11.2 | - | 1.46 | -14.1% | -19.6% |
Performance Comparison: AKYA vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AKYA
| Total Return (including Dividends) | AKYA | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 17.24% | 2.14% | 5.25% |
| 3 Months | 16.24% | 0.64% | 24.13% |
| 12 Months | -34.93% | -4.57% | 14.15% |
| 5 Years | -94.78% | 42.89% | 111.83% |
| Trend Score (consistency of price movement) | AKYA | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 64.3% | 35.8% | 81% |
| 3 Months | 46.2% | -28.5% | 96.9% |
| 12 Months | -67.6% | -74.5% | 44.9% |
| 5 Years | -95.2% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th90.50 | 14.78% | 11.40% |
| 3 Month | %th66.00 | 15.50% | -6.36% |
| 12 Month | %th25.50 | -31.81% | -43.00% |
| 5 Years | %th15.00 | -95.63% | -96.72% |
FAQs
Does Akoya Biosciences (AKYA) outperform the market?
No,
over the last 12 months AKYA made -34.93%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.57%.
Over the last 3 months AKYA made 16.24%, while XLV made 0.64%.
Performance Comparison AKYA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
AKYA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 8% | 12% | -50.6% | -49% |
| US NASDAQ 100 | QQQ | 8.2% | 11.9% | -51.3% | -48% |
| German DAX 40 | DAX | 10.1% | 18.7% | -62.8% | -64% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 8.1% | 14% | -54% | -55% |
| Hongkong Hang Seng | HSI | 8.4% | 11.2% | -70.1% | -73% |
| India NIFTY 50 | INDA | 9.8% | 13.8% | -50.9% | -34% |
| Brasil Bovespa | EWZ | 5.5% | 8.4% | -75.7% | -45% |
AKYA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 9.4% | 11.3% | -54.7% | -59% |
| Consumer Discretionary | XLY | 8.5% | 14.1% | -43% | -53% |
| Consumer Staples | XLP | 7.7% | 16.6% | -52.3% | -44% |
| Energy | XLE | 7.7% | 10.2% | -46.5% | -35% |
| Financial | XLF | 7.3% | 12.2% | -55.5% | -65% |
| Health Care | XLV | 8.5% | 15.1% | -43.3% | -30% |
| Industrial | XLI | 7.9% | 13% | -58.5% | -60% |
| Materials | XLB | 5.7% | 13% | -55.1% | -41% |
| Real Estate | XLRE | 8% | 16.3% | -50.3% | -48% |
| Technology | XLK | 7.2% | 8.6% | -52.9% | -46% |
| Utilities | XLU | 9.1% | 15.5% | -53.8% | -58% |
| Aerospace & Defense | XAR | 10.1% | 10.2% | -69.2% | -84% |
| Biotech | XBI | 7% | 13.9% | -37.4% | -28% |
| Homebuilder | XHB | 5.5% | 10.2% | -43.4% | -40% |
| Retail | XRT | 5.4% | 12.3% | -46.3% | -46% |
AKYA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 7.1% | 8.80% | -42.2% | -27% |
| Natural Gas | UNG | 17.5% | 27.1% | -33.8% | -33% |
| Gold | GLD | 7.7% | 18.5% | -71.2% | -74% |
| Silver | SLV | 7% | 10.3% | -68% | -53% |
| Copper | CPER | 8.9% | 12.7% | -67.7% | -46% |
AKYA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 9.8% | 16.2% | -47.2% | -33% |
| iShares High Yield Corp. Bond | HYG | 9.2% | 15.6% | -49.5% | -45% |